Biotech

All Articles

Aligos heralds stage 2 MASH win, slashing liver excess fat up to 46%

.Aligos Therapeutics is actually trumpeting a midstage succeed in metabolic-dysfunction linked steat...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job developing brand-new antifungals has gotten a significant improvement f...

Capricor markets Europe liberties to late-stage DMD treatment for $35M

.Possessing currently gathered up the USA legal rights to Capricor Therapeutics' late-stage Duchenne...

FDA scraps adcomm for Applied's rare ailment medication

.After dismissing the selection meeting for Applied Therapies' metabolic condition medicine govorest...

Novo inks $600M NanoVation deal to research genetic medicines ex-liver

.Novo Nordisk is actually proceeding its own press into hereditary medications, agreeing to compensa...

Innovent hyperlinks cytokine to colorectal cancer actions

.Innovent Biologics has helped make the instance that its own gate inhibitor-cytokine fusion healthy...

Merck, Daiichi ADC reaches objective in phase 3 lung cancer research

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina deepens artificial intelligence concentrate with collab to decide on cancer cells aim ats

.5 months after Rakovina Therapies pivoted toward expert system, the cancer-focused biotech has part...

Ascendis' dwarfism drug hits in phase 3, intimidates BioMarin

.Ascendis Pharma has become a possible threat to BioMarin's Voxzogo, stating stage 3 development ail...

Despite ph. 3 overlook, Alkeus views course in advance for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye illness resource failed to significantly minimize geographi...